Stocks股票 / Health Care / TMO

Thermo Fisher Scientific · Health Care

TMO US listed · USD美股 · 美元

Thermo Fisher Scientific Inc. is an American life science and clinical research company.Thermo Fisher Scientific Inc. 是一家美国生命科学和临床研究公司。

Large cap大盘 · $195B Mixed profile混合特征 Health Care S&P 500标普500
$526.23
-$6.25 · -1.17%
52w low52周低 $402high $643
Neutral — no clear edge中性 — 无明显优势 The bottoming setup is not yet confirmed (price still below the 10-day average) and oscillators are already extended/overbought — not a safe entry. Wait for…筑底形态尚未确认(价格仍位于 10 日均线下方),且摆动指标已过热——此处入场风险较高。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。 Engine read引擎解读 · 2026-07-21

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动

Technicals技术面

daily bars日线数据 · 2026-07-21
Ichimoku — Price Above Cloud
Momentum (RSI 14)动量(RSI 14) 59
Neutral zone中性区域
vs 50-day average相对50日均线 +8.5% above上方 Uptrend intact趋势完好
vs 200-day average相对200日均线 -0.5% below下方 Long trend down长期向下
Trend strength (ADX)趋势强度(ADX) 35 Strong trend趋势强劲
Volatility波动率 50th percentile第50百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源,每晚更新。

Earnings财务业绩

next report下次财报 2026-07-22
2days to go天后公布

Estimates being cut预期下调

Post-earnings drift: -8.1% (20d)财报后漂移:-8.1%(20日)

Valuation估值

Roughly fair vs sector相对行业估值合理
Multiple指标TMO Sector median行业中位Cheaper than相对便宜
P/E (trailing)市盈率(历史) 29.09x 28.59 46%
P/E (forward)市盈率(预测) 19.3x
P/B市净率 3.66x 3.44 46%
P/S市销率 4.39x 2.97 32%
Earnings yield盈利收益率 3.44% 2.72 60%
FCF yield自由现金流收益率 3.22% 4.00 40%
Shareholder yield股东收益率 1.86% 1.89 50%
EV/EBITDA企业价值/EBITDA 25.96x 18.18 27%
P/FCF市值/自由现金流 31.06x 22.08 31%
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。

Financials财务数据

fiscal years财年
Revenue营业收入
$32.2B2020
$39.2B2021
$44.9B2022
$42.9B2023
$42.9B2024
$44.6B2025
5-yr growth5年复合增速 6.7%
Earnings per share每股收益
$15.962020
$19.462021
$17.632022
$15.452023
$16.532024
$17.742025
5-yr growth5年复合增速 2.1%
Free cash flow自由现金流
$6.8B2020
$6.8B2021
$6.9B2022
$6.9B2023
$7.3B2024
$6.3B2025
Operating margin营业利润率
17.4%
Net margin净利率
15.1%
FCF margin自由现金流利润率
17.5%
Balance-sheet quality财务体质 4/7 Bankruptcy risk: safe zone破产风险:安全区 Return on equity股本回报率 13% Clean稳健

Leverage杠杆

Net debt / EBITDA净债务/EBITDA3.73
Current ratio流动比率1.89

Capital allocation资本配置

Buybacks (TTM)回购(TTM)$3.0B
Stock-based comp股权薪酬$310.0M
Share count change (1y)股数变化(1年)-1.5%

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Sector / Theme行业/主题 Health Care (Equal-Weight) theme — #8 of 46 themes「医疗保健(等权)」主题 — 46 个主题中第 8 位
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed +21.1%空头仓位变动 +21.1%
Technical技术面 TMO lost its 200-day averageTMO 跌破200日均线

Options positioning期权持仓

as of last close截至上一收盘

Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡

Expected daily move预期日波动
±2.52%
Expected weekly move预期周波动
±5.64%
Gamma flip伽玛翻转位
$503
25d risk reversal25d风险逆转
-6.2%
Skew: fear偏斜:避险
Call and put walls are plotted on the Trade levels ladder →看涨/看跌期权墙已标注在「交易点位」阶梯上 →

Ownership & smart money持仓与聪明钱

13F

Insider activity:内部人动向: -$96.4M net (0 buyers, 6 sellers)-$96.4M 净值(0 买家,6 卖家)

Concentrated ownership集中持仓

Fund基金Grade评级 Latest move最新动作% of book组合占比As of截至
D1 Capital Partners A New position新建仓 3.2% 2026-03-31
Viking Global (Halvorsen) B Adding加仓 2.3% 2026-03-31
Third Point (Loeb) B exitexit 0.0% 2026-03-31
Polen Capital Management B exitexit 0.0% 2026-03-31

Signal history信号历史

engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中 BUY SETUP. Buyers rejected the 2026-06-17 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-06-17 的低点(摆动低点已现),但价格尚未收复 10 日均线——第一项条件达成,并非全部
Jul 20, 2026
TMO lost its 200-day averageTMO 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $526.23.收盘跌破200日均线 — 经典的空头分界线。$526.23。
Jul 16, 2026
TMO RSI reached overboughtTMO RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $543.19.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$543.19。
Jul 15, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 13, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Jul 10, 2026
TMO reclaimed its 200-day averageTMO 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $527.05.收盘重回200日均线 — 经典的多头分界线。$527.05。
Jul 8, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Jul 1, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Showing the last 15 of显示最近15条,共 3844 signals条信号

Company profile公司档案

Thermo Fisher Scientific Inc. is an American life science and clinical research company.Thermo Fisher Scientific Inc. 是一家美国生命科学和临床研究公司。

Demand chain:需求链: Contracted bookings (RPO) accelerating (+13% YoY to ~$28B, 0.6× revenue) — signed demand locked in ahead of recognition已签约订单(RPO)加速(同比+13%,约 $28B,覆盖营收 0.6 倍)——已锁定、尚未确认的需求

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Below market低于市场

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考,不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-07-21 · regenerated nightly每晚更新 · Generated生成于 2026-07-21 02:08 UTC · All coverage所有股票 · Analyzer分析器